Akso Health Group (NASDAQ:AHG) Sets New 12-Month High – Should You Buy?

Akso Health Group Sponsored ADR (NASDAQ:AHG) reached a new 52-week high during mid-day trading on Thursday . The company traded as high as $2.4357 and last traded at $2.20, with a volume of 223465 shares. The stock had previously closed at $1.78.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Akso Health Group in a report on Wednesday, January 21st. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock has a consensus rating of “Sell”.

Akso Health Group Stock Up 23.6%

The firm has a 50 day moving average price of $1.46 and a 200-day moving average price of $1.55.

Institutional Trading of Akso Health Group

A hedge fund recently bought a new stake in Akso Health Group stock. SmartHarvest Portfolios LLC acquired a new stake in shares of Akso Health Group Sponsored ADR (NASDAQ:AHG) in the 4th quarter, according to its most recent 13F filing with the SEC. The fund acquired 16,748 shares of the company’s stock, valued at approximately $27,000. Institutional investors own 1.21% of the company’s stock.

About Akso Health Group

Akso Health Group operates a social e-commerce mobile platform in China. The company operates Xiaobai Maimai App, which offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. It also offers consultancy and information technology support services; provides health treatment services; sells medical devices; and trades in branded products, as well as promotes products. The company was formerly known as Xiaobai Maimai Inc and changed its name to Akso Health Group in December 2021.